Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA OTC label survey participants include many under age 45.

This article was originally published in The Tan Sheet

Executive Summary

"COMPLETE RELIEF" LABEL CLAIM STRONGER THAN "COMPLETELY EFFECTIVE," CONSUMERS suggest in responses to an FDA study on OTC drug label format preferences. In one component of the OTC Label Format Preference survey, also known as Study B, the 904 participants were asked how effective (on a scale of zero to 10) they thought a drug would be based on how it was described to them. Two-thirds of the subjects rated the term "complete relief" a nine or 10, but when asked a similar question about effectiveness, fewer than half (45.6%) of the subjects gave the term "completely effective" a nine or 10 rating. FDA posted the results on its Web site (www.fda.gov) the week of Dec. 29.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS087940

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel